Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004440 |
---|---|
Receipt number | R000005298 |
Scientific Title | A phase ll study to show the feasibility of six months continuous administration of Docetaxel+TS-1 for patients with Stage lllA/lllB gastric cancer after surgical resection (OGSG 1002) |
Date of disclosure of the study information | 2010/11/01 |
Last modified on | 2022/11/06 12:23:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/10/25 17:17:57 | ||
2 | Update | 2011/03/04 17:24:17 | Recruitment status Anticipated trial start date Last follow-up date |
|
3 | Update | 2011/11/22 19:12:01 | Organization Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2011/11/30 17:54:22 | Last follow-up date |
|
5 | Update | 2012/06/24 23:03:03 | Public title Public title Acronym Acronym |
|
6 | Update | 2012/06/24 23:06:17 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Address Address TEL Organization1 Address1 Tel1 Email1 |
|
7 | Update | 2013/04/26 21:21:53 | Recruitment status Last follow-up date |
|
8 | Update | 2013/05/28 21:34:31 | Anticipated trial start date Last follow-up date |
|
9 | Update | 2014/07/27 22:18:07 | Organization Organization Address Address TEL Institutions |
|
10 | Update | 2014/07/27 22:31:01 | Last follow-up date Date analysis concluded |
|
11 | Update | 2014/07/27 22:32:05 | Last follow-up date Date analysis concluded |
|
12 | Update | 2014/07/27 22:41:16 | Institutions |
|
13 | Update | 2014/07/27 23:11:52 | Institutions |
|
14 | Update | 2015/05/28 00:05:41 | Email |
|
15 | Update | 2018/05/10 20:24:54 | Email Name of primary person or sponsor Organization |
|
16 | Update | 2018/08/02 21:46:08 | UMIN ID1 |
|
17 | Update | 2018/08/02 21:48:18 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Institute |
|
18 | Update | 2018/10/30 21:30:49 | Recruitment status Last follow-up date Date analysis concluded |
|
19 | Update | 2020/01/05 13:43:10 | Date of IRB Date analysis concluded |
|
20 | Update | 2020/01/22 21:28:02 | Date of IRB |
|
21 | Update | 2022/11/06 12:23:44 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |